Home - News and Events - News - VASCERN statements concerning SARS-CoV-2 vaccination
January 29 2021

VASCERN statements concerning SARS-CoV-2 vaccination

covid vaccination

With vaccination programs against SARS-CoV-2 already underway across Europe, VASCERN’s Rare Disease Working Groups have produced individual statements for their patients when it comes to COVID-19 vaccinations. The following statements are now available:

Hereditary Haemorrhagic Telangiectasia (HHT)

Heritable Thoracic Aortic Diseases (HTAD)

 Medium-Sized Arteries (MSA) Working Group – vascular Ehlers-Danlos syndrome (vEDS)

 Vascular Anomalies (VASCA)

Pediatric and Primary Lymphedema (PPL)

As a reminder, you can find all of VASCERN’s COVID-19 recommendations by clicking the button on the homepage here.

For more info on the European Commission’s Common European coronavirus response, please click here

For a list of COVID-19 resources and recommendations (including those of VASCERN and the other ERNs) collected by Eurordis click here, and by Orphanet click here.

Skip to content